Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1).
about
Predictive biomarkers in precision medicine and drug development against lung cancerAntitumor activity of a novel oncrasin analogue is mediated by JNK activation and STAT3 inhibitionProdrug oncrasin-266 improves the stability, pharmacokinetics, and safety of NSC-743380Antagonistic effect of flavonoids on NSC-741909-mediated antitumor activity via scavenging of reactive oxygen species.Development of synthetic lethality anticancer therapeutics.Analogues and derivatives of oncrasin-1, a novel inhibitor of the C-terminal domain of RNA polymerase II and their antitumor activities.Expression of sulfotransferase SULT1A1 in cancer cells predicts susceptibility to the novel anticancer agent NSC-743380Antitumor activity of a novel STAT3 inhibitor and redox modulator in non-small cell lung cancer cellsRAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studies.Hedgehog pathway and GLI1 isoforms in human cancer.Approaches to Ras signaling modulation and treatment of Ras-dependent disorders: a patent review (2007--present).Genetic Interactions of STAT3 and Anticancer Drug Development.Synthesis and biological evaluation of novel 6-hydrazinyl-2,4-bismorpholino pyrimidine and 1,3,5-triazine derivatives as potential antitumor agents.Anti-leukemia activity of NSC-743380 in SULT1A1-expressing acute myeloid leukemia cells is associated with inhibitions of cFLIP expression and PI3K/AKT/mTOR activities.
P2860
Q26824536-8AEE8459-0B4A-4DB8-A662-5D608514C1D0Q34103117-73C13307-192A-490E-BC66-CF8DCC458729Q34231935-2985D099-B87D-4138-B567-4651E45BED62Q34259118-4A4BC421-375F-4F60-BF34-6037B1FE5FBCQ34380368-EE1C2119-769C-4425-B5BE-D3F33E61F98BQ34857289-C8771D22-2043-4676-9822-194490FC9A2FQ35238466-E6754F04-5971-419A-94A4-FED8B8F1DB5BQ36081620-26DB6001-4BB0-42BD-9430-48252C645FAEQ36398735-E933E5A6-7115-4A4A-A654-910682B47BF9Q37988650-FD772A8B-258A-401C-8B90-67E0C0C5948BQ38046230-ACD59D62-BA27-44D6-A8F7-E633CDFD09FAQ38198930-112F62F9-1566-470F-9BA8-4FF4567518D5Q39329615-2A7728F6-1CE9-4D3A-A767-73EDA7C352A9Q46237281-A260754C-EA21-4A7E-A3C1-2876A6433720
P2860
Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interruption of RNA processing ...... 3-carboxaldehyde (oncrasin-1).
@en
Interruption of RNA processing ...... 3-carboxaldehyde (oncrasin-1).
@nl
type
label
Interruption of RNA processing ...... 3-carboxaldehyde (oncrasin-1).
@en
Interruption of RNA processing ...... 3-carboxaldehyde (oncrasin-1).
@nl
prefLabel
Interruption of RNA processing ...... 3-carboxaldehyde (oncrasin-1).
@en
Interruption of RNA processing ...... 3-carboxaldehyde (oncrasin-1).
@nl
P2093
P2860
P1476
Interruption of RNA processing ...... 3-carboxaldehyde (oncrasin-1).
@en
P2093
Bingliang Fang
Jinsong Liu
Rui-yu Wang
Shuhong Wu
Xiaoli Wei
P2860
P304
P356
10.1158/1535-7163.MCT-08-0839
P577
2009-02-10T00:00:00Z